Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 1,629.15
-18.10 (-1.10%)
At close: Jul 27, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 40.23 billion as of July 27, 2026. Its market cap has increased by 59.91% in one year.
Market Cap
40.23B
Enterprise Value
33.58B
Revenue
3.71B
Ranking
n/a
PE Ratio
41.14
Stock Price
1,629.15
ChartMarket Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 40.23B, an increase of 219.62%. That is a compound annual growth rate of 4.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 40.23B | 109.13% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Procter & Gamble Health | 111.61B |
| Viyash Scientific | 109.55B |
| Sanofi India | 78.02B |
| FDC Limited | 66.96B |
| Bliss GVS Pharma | 49.16B |
| Unichem Laboratories | 37.97B |
| Gufic Biosciences | 37.93B |
| Morepen Laboratories | 29.47B |